The Lancet Oncology · 2014 · 695 citations · 21 references
MedicineOncologyPharmacologyCancer PharmacologyMetastasisOncology PharmacotherapyBrain Metastasis ManagementLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsMetastatic Disease TreatmentTargeted Cancer TherapyAlk InhibitionAnaplastic Lymphoma Kinase InhibitionAnaplastic Lymphoma Kinase InhibitorsBrain Metastasis TrialsDose-finding Trial DesignNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
21
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Manabu Soda, Young Lim Choi, Munehiro Enomoto et al. · Nature · 2007 · 5.4K citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +15
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Klarisa Rikova, Ailan Guo, Qingfu Zeng et al. · Cell · 2007 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +16